Table 2.
Main diagnoses | N = 351 |
---|---|
Priority conditions/infections of the central nervous system* | 63 (17.9) |
Unspecified meningoencephalitis | 19 (5.4) |
Bacterial meningitis with specified pathogen | 14 (4.0) |
due to Neisseria meningitidis | 12 (3.4) |
HIV and related opportunistic infections | 10 (2.8) |
Second-stage human African trypanosomiasis | 10 (2.8) |
Cerebral malaria | 5 (1.4) |
Tuberculosis of the central nervous system | 4 (1.1) |
Neurosyphilis | 1 (0.3) |
Other local/systemic infections with neurological manifestations | 60 (17.1) |
Upper/lower respiratory tract infection | 18 (5.1) |
Undifferentiated febrile illness (viral or bacterial) | 17 (4.6) |
Uncomplicated malaria | 10 (2.8) |
Spinal tuberculosis | 9 (2.5) |
Tetanus | 3 (0.8) |
Bacteremia | 3 (0.8) |
Noncommunicable neurological illnesses/syndromes | 162 (46.1) |
Epilepsy | 61 (17.3) |
Cerebrovascular accident | 23 (6.6) |
Neuropathic syndromes | 19 (5.4) |
Degenerative neurological diseases | 18 (5.1) |
Dementia | 9 (2.6) |
Extrapyramidal disorders | 6 (1.7) |
Motor neuron disorders | 3 (0.8) |
Myelopathic syndrome | 12 (3.4) |
Headache syndrome, unspecified | 9 (2.5) |
Spondylarthropathy, unspecified | 7 (1.9) |
Vestibular syndrome | 6 (1.7) |
Migraine | 4 (1.1) |
Space-occupying lesion | 3 (0.8) |
Psychiatric disorders | 56 (16.0) |
Anxiety depression | 42 (12.0) |
Psychosis | 14 (3.9) |
Metabolic or vascular diseases with neurological manifestations | 10 (2.8) |
Arterial hypertension | 4 (1.1) |
Hyperglycemia | 2 (0.5) |
Hypoglycemia | 2 (0.5) |
Temporalis arteritis | 2 (0.5) |
DRC = Democratic Republic of Congo; HIV = human immunodeficiency virus. All results are expressed as n, (%).
Diagnosis of the priority conditions was obtained with the following investigations (see also Supplemental Table 2): unspecified meninogoencephalitis (presence of > 5 white blood cells (with neutrophil or lymphocyte predominance) in cerebrospinal fluid (CSF) and no etiological pathogen demonstrated (N = 19); bacterial meningitis: positive culture (N = 4); positive Gram stain in cerebrospinal fluid with confirmation by Pastorex antigen test (N = 7), or not (N = 2); positive Pastorex antigen test only (N = 1); human African trypanosomiasis: demonstration of trypanosomes in CSF only (N = 4), in blood and CSF (N = 4), in blood, CSF and lymph node (N = 2); HIV-related neurological disorders: HIV infection confirmed by three successive positive rapid diagnostic tests, with unspecified meningoencephalitis (N = 4), cryptococcal meningitis (N = 3), or cerebral toxoplasmosis (N = 3); cerebral malaria: signs of cerebral dysfunction and blood smear positive for Plasmodium falciparum trophozoites + and exclusion of other etiologies (N = 5); tuberculosis of central nervous system: positive Ziehl stain and GeneXpert in CSF (N = 1), positive GeneXpert in CSF only (N = 2), and abnormal CSF and demonstrated pulmonary tuberculosis (N = 1); and neurosyphilis: positive rapid plasma reagin and Treponema pallidum passive particle agglutination in blood and positive venereal disease research laboratory test in CSF (N = 1).